Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Legit62on Dec 18, 2022 11:56am
287 Views
Post# 35178398

RE:RE:RE:RE:RE:RE:RE:NSCLC and GBM indications

RE:RE:RE:RE:RE:RE:RE:NSCLC and GBM indications Couldnt agree more StevenBirch, i think for the most part, those that are still here in this investment are looking at a new treatment option that provides hope with less treatments, less toxicity, less cost and beneficial results. I guess what the final outcome will be will depend on the Data and nothing else, if the FDA agrees we are all set, if they dont then we wasted years in this, or they push us out more years, which i personally doubt but i dont decide the fate of this. So I believe we get an answer within 2 to 3 months, then we dont have to SPECULATE anymore. Hopefully the payout will be substantial. No guarantees so its good to see opposing opinions, but always remember, it is you,not them that decides to stay or sell. Have a Great Christmas and New Years all you here
<< Previous
Bullboard Posts
Next >>